Diabetes (2024) 2
That doesnt remove the need for caution
In fact, the pharmacokinetics (how the drug is absorbed and processed) are designed for slow, steady release from a once-weekly injection
However, GLP-1 receptor agonists had no significant effects on the occurrence of thyroid cancer (RR 1.30, 95% CI 0.86-1.97), hyperthyroidism (RR 1.19, 95% CI 0.61-2.35), hypothyroidism (RR 1.22, 95% CI 0.80-1.87), thyroiditis (RR 1.83, 95% CI 0.51-6.57), thyroid mass (RR 1.17, 95% CI 0.43-3.20), and goiter (RR 1.17, 95% CI 0.74-1.86)
From medical weight loss to aesthetic and regenerative therapies, every treatment is designed for real, visible, lasting results at every stage of life